trending Market Intelligence /marketintelligence/en/news-insights/trending/wlpjsu3tlywmlkmdhevfka2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Cutera's nonsurgical fat removal system gets US FDA clearance for expanded use

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Cutera's nonsurgical fat removal system gets US FDA clearance for expanded use

The U.S. Food and Drug Administration cleared Cutera Inc.'s nonsurgical body sculpting system truSculpt 3D for lipolysis, or the breakdown of fat.

The device previously has FDA clearance for the reduction of fat without surgery.

Brisbane, Calif.-based Cutera is a medical device company that designs, develops, manufactures, markets and services laser and other energy-based aesthetics systems worldwide.